Eun Mi Nam
About
Eun Mi Nam is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery.
According to data from OpenAlex, Eun Mi Nam has authored 45 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Public Health, Environmental and Occupational Health and 13 papers in Surgery. Recurrent topics in Eun Mi Nam's work include Palliative Care and End-of-Life Issues (15 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Eun Mi Nam is often cited by papers focused on Palliative Care and End-of-Life Issues (15 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Eun Mi Nam collaborates with scholars based in South Korea, United States and Ethiopia. Eun Mi Nam's co-authors include Soon Nam Lee, Kyoung Eun Lee, Do Yeun Kim, Sang‐Cheol Lee, Se Hoon Park, Joon Oh Park, Hye Sung Won, Jung Yong Hong, Seong Ho Choi and Young Suk Park and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgical Oncology.
In The Last Decade
Eun Mi Nam
39 papers receiving 517 citations
Peers
Eun Mi Nam
Po‐Jung Su Taiwan
Biren Saraiya United States
Nicholas Zdenkowski Australia
Yasuhiko Miura Japan
Mary Coerver- Connolly Ireland
Rachel Yang United States
Hye Jung Chang South Korea
Qin Cheng China
Guorong Wang China
Anne Van Arsdale United States
Citations per year, relative to Eun Mi Nam Eun Mi Nam (= 1×)
peers
Po‐Jung Su
Countries citing papers authored by Eun Mi Nam
Since
Specialization
Citations
This map shows the geographic impact of Eun Mi Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Mi Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Mi Nam more than expected).
Fields of papers citing papers by Eun Mi Nam
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eun Mi Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Mi Nam. The network helps show where Eun Mi Nam may publish in the future.
Co-authorship network of co-authors of Eun Mi Nam
This figure shows the co-authorship network connecting the top 25 collaborators of Eun Mi Nam. A scholar is included among the top collaborators of Eun Mi Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Mi Nam. Eun Mi Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kang, EunKyo, Su‐Jin Koh, Jung Hun Kang, et al.. (2025). Quality Matters: Effect of High-Quality Early Palliative Care in Advanced Cancer. Journal of Pain and Symptom Management. 70(6). 638–648.
2.
Kim, Hong Jun, Eun Hee Jung, Jung Hye Kwon, et al.. (2024). Psychometric Validation of Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients. Cancer Research and Treatment. 57(3). 891–898.
3.
Kang, EunKyo, Jung Hun Kang, Su‐Jin Koh, et al.. (2024). Early Integrated Palliative Care in Patients With Advanced Cancer. JAMA Network Open. 7(8). e2426304–e2426304.
4.
Kim, Min Jung, Dae Won Lee, Hyun‐Cheol Kang, et al.. (2023). Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial. BMC Cancer. 23(1). 734–734.
5.
Jo, Hyunji, Seri Park, Hye Ryeon Kim, et al.. (2022). Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort. Cancers. 14(19). 4839–4839.
6.
Yun, Young Ho, EunKyo Kang, Sohee Park, et al.. (2019). Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial. Journal of Pain and Symptom Management. 58(6). 940–948.e2.
7.
Kim, Do Yeun, et al.. (2019). Factors That Influence Attitudes Toward End-of-Life Care Among Medical Students: Nationwide Survey for Fourth-Year Korean Medical Students. American Journal of Hospice and Palliative Medicine®. 36(6). 460–465.
8.
Yoo, Shin Hye, Jihye Lee, Jung Hun Kang, et al.. (2019). Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members. Supportive Care in Cancer. 28(6). 2959–2967.
9.
Park, Hye Yoon, Young Ae Kim, Jin-Ah Sim, et al.. (2018). Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act. Journal of Pain and Symptom Management. 57(4). 774–782.
10.
Yun, Young Ho, Kyoung‐Nam Kim, Jin-Ah Sim, et al.. (2018). Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population. BMJ Open. 8(9). e020519–e020519.
11.
Kim, Ji Young, Soomin Ahn, Kyubo Kim, et al.. (2018). Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial–Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy. Anticancer Research. 38(12). 6881–6889.
12.
Kim, Yi‐Jun, Eui Kyu Chie, Do‐Youn Oh, et al.. (2017). Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy. International Journal of Clinical Oncology. 22(6). 1069–1075.
13.
Choi, Jung Eun, et al.. (2016). Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report. Chemotherapy. 62(1). 54–57.
14.
Hwang, In Gyu, Joung-Soon Jang, Sung Yong Oh, et al.. (2015). Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer. Cancer Chemotherapy and Pharmacology. 75(4). 757–762.
15.
Hong, Jung Yong, Eun Mi Nam, Jeeyun Lee, et al.. (2013). Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients. Cancer Chemotherapy and Pharmacology. 73(1). 125–130.
16.
Nam, Eun Mi. (2010). Recent advances in the treatment of patients with colorectal liver metastases. The Korean Journal of Internal Medicine. 79(2). 125–132.
17.
Nam, Eun Mi, et al.. (2008). Assessing cancer treatment related information online: unintended retrieval of complementary and alternative medicine web sites. European Journal of Cancer Care. 18(1). 64–68.
18.
Kim, Do Yeun, Kyoung Eun Lee, Eun Mi Nam, et al.. (2007). Do-Not-Resuscitate Orders for Terminal Patients with Cancer in Teaching Hospitals of Korea. Journal of Palliative Medicine. 10(5). 1153–1158.
19.
Lee, Beom Jae, Yeung‐Chul Mun, Hye Jung Chang, et al.. (2007). The Results of Danazol Therapy in Patients with Chronic Immune Thrombocytopenic Purpura Who Failed with Corticosteroid Therapy. The Korean Journal of Hematology. 42(4). 353–353.
20.
Kim, Yeul Hong, et al.. (2002). Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer. International Journal of Clinical Oncology. 7(2). 114–119.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Po‐Jung Su Breakdown of academic impact, for papers by Biren Saraiya Breakdown of academic impact, for papers by Nicholas Zdenkowski Breakdown of academic impact, for papers by Yasuhiko Miura Breakdown of academic impact, for papers by Mary Coerver- Connolly Breakdown of academic impact, for papers by Rachel Yang Breakdown of academic impact, for papers by Hye Jung Chang Breakdown of academic impact, for papers by Qin Cheng Breakdown of academic impact, for papers by Guorong Wang Breakdown of academic impact, for papers by Anne Van Arsdale